News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Celgene (CELG) Subsidiary Pharmion Corporation (PHRM) Withdraws European Marketing Application for Orplatna


8/14/2008 6:37:08 AM

Celgene Europe has told the European Medicines Agency (EMEA) that its Pharmion subsidiary is withdrawing a marketing application for Orplatna because the EMEA’s Committee for Medicinal Products for Human Use does not think the cancer drug’s benefits outweigh its risks.

Read at press release


comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES